首页|期刊导航|中华医学杂志（英文版）|Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong,China
Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong,China
Yaozu He Weiping Cai Xiaoping Tang Linghua Li Weiyin Lin Hong Li Fei Gu Huolin Zhong Yun Lan Yonghong Li Pengle Guo Fengyu Hu
中华医学杂志（英文版）2023，Vol.136Issue(22)：2686-2693,8.
中华医学杂志（英文版）2023，Vol.136Issue(22)：2686-2693,8.DOI:10.1097/CM9.0000000000002886
Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong,China
Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong,China
摘要
关键词
HBV/HIV co-infection/HBsAg seroclearance/Predictor/ALT elevation/HBV genotype/Hepatitis B surface anti-gens/Tenofovir disoproxil fumarateKey words
HBV/HIV co-infection/HBsAg seroclearance/Predictor/ALT elevation/HBV genotype/Hepatitis B surface anti-gens/Tenofovir disoproxil fumarate引用本文复制引用
Yaozu He,Weiping Cai,Xiaoping Tang,Linghua Li,Weiyin Lin,Hong Li,Fei Gu,Huolin Zhong,Yun Lan,Yonghong Li,Pengle Guo,Fengyu Hu..Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong,China[J].中华医学杂志（英文版）,2023,136(22):2686-2693,8.基金项目
The present study was supported by the National Key Research and Development Program of China(No.2022YFC2304800),Science and Technology Project of Guangzhou(Nos.2023A03J0792,20220020285),National Natural Science Foundation of China(No.82072265),Science and Technology Program of Guangzhou(No.202102020074),and Medical Key Discipline Program of Guangzhou-Viral Infectious Diseases(No.2021-2023). （No.2022YFC2304800）
